CoChat

Elevated Iron Status Strongly Predicts Mortality in West African Adults With HIV Infection

McDermid, Joann M, Jaye, Assan, Schim van der Loeff, Maarten F, Todd, Jim, Bates, Chris, Austin, Steve, Jeffries, David, Awasana, Akum A, Whittle, Hilton C, Prentice, Andrew M · 2007 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Cited by 91

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To comprehensively assess iron status and determine whether elevated iron status, like anemia, predicts mortality. METHODS: We followed 1362 Gambian adults (53% female) in an HIV-seroprevalent clinic-based cohort over 11.5 years to ascertain all-cause mortality. Baseline iron status (iron, soluble transferrin receptor [sTfR], transferrin, ferritin, transferrin saturation, log [transferrin receptor: ferritin]), age, gender, ethnicity, hemoglobin, body mass index, HIV type, absolute CD4 count, malaria status, and [alpha]-(1)-antichymotrypsin were measured. RESULTS: The mortality rate was 25.9/100 person-years. Elevated iron universally predicted greater mortality compared to normal iron status for all iron status indices, with the exception of sTfR in unadjusted models. In fully adjusted models, transferrin (elevated vs. normal, hazard ratio [HR]: 1.77; 95% confidence interval [CI]: 1.30 to 2.42; P < 0.001), ferritin (elevated vs. normal, HR: 1.40; 95% CI: 1.07 to 1.83; P = 0.014), and the combined iron status index (highly elevated vs. normal, HR: 2.20; 95% CI: 1.16 to 4.18; P = 0.016) remained significant predictors. As expected, hemoglobin (Hb) concentration and absolute CD4 counts were each inversely associated with mortality. CONCLUSIONS: Elevated iron status predicts mortality in HIV infection, even after adjustment for immunosuppression and other confounders. This finding has implications in the clinical monitoring of disease progression and for iron-supplementation practices in areas of high HIV prevalence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qai.0b013e31815b2d4b

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. McDermid, 2006, Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV., Clin Sci (Lond), 110, 503, 10.1042/CS20050273 · DOI · Paper page
  2. Sullivan, 1998, Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project., Blood, 91, 301, 10.1182/blood.V91.1.301 · DOI · Paper page
  3. Moore, 1999, Human immunodeficiency virus infection, anemia, and survival., Clin Infect Dis, 29, 44, 10.1086/520178 · DOI · Paper page
  4. Mocroft, 1999, Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group., AIDS, 13, 943, 10.1097/00002030-199905280-00010 · DOI · Paper page
  5. Gordeuk, 2006, The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection., Haematologica, 91, 739
  6. Balakrishnan, 2005, Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries., Indian J Med Res, 121, 345
  7. Tucker, 2001, Laboratory monitoring of HIV-after access to antiretroviral drugs, the next challenge for the developing world., S Afr Med J, 91, 615
  8. Stephenson, 2002, Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment., JAMA, 288, 151, 10.1001/jama.288.2.151 · doi:10.1001/jama.288.2.151
  9. Schim van der Loeff, 2002, Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia., AIDS, 16, 1775, 10.1097/00002030-200209060-00010 · DOI
  10. Hill, 1991, Common west African HLA antigens are associated with protection from severe malaria., Nature, 352, 595, 10.1038/352595a0 · DOI · Paper page
  11. Milman, 1990, Serum ferritin, iron status and plasma ascorbic acid in 40- to 49-year- old males in the Faroe Islands., Scand J Clin Lab Invest, 50, 559, 10.1080/00365519009089171 · doi:10.1080/00365519009089171
  12. Malope, 2001, The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status., Br J Haematol, 115, 84, 10.1046/j.1365-2141.2001.03063.x · DOI · Paper page
  13. Mainous, 2004, 3rd, Gill JM, Carek PJ. Elevated serum transferrin saturation and mortality., Ann Fam Med, 2, 133, 10.1370/afm.25 · DOI
  14. Mainous, 2004, 3rd, Wells B, Carek PJ, et al. The mortality risk of elevated serum transferrin saturation and consumption of dietary iron., Ann Fam Med, 2, 139, 10.1370/afm.82 · DOI
  15. Khumalo, 1998, Serum transferrin receptors are decreased in the presence of iron overload., Clin Chem, 44, 40, 10.1093/clinchem/44.1.40 · DOI
  16. Allen, 1998, Measurement of soluble transferrin receptor in serum of healthy adults., Clin Chem, 44, 35, 10.1093/clinchem/44.1.35 · DOI
  17. van der Sande, 2004, Body mass index at time of HIV diagnosis: a strong and independent predictor of survival., J Acquir Immune Defic Syndr, 37, 1288, 10.1097/01.qai.0000122708.59121.03 · DOI · Paper page
  18. Gomo, 2003, Reference values and predictors of white blood cell subset counts: a cross-sectional study among HIV seronegative pregnant women in Zimbabwe., Eur J Obstet Gynecol Reprod Biol, 107, 156, 10.1016/S0301-2115(02)00346-9 · doi:10.1016/s0301-2115(02)00346-9
  19. Sullivan, 2002, Associations of anemia, treatments for anemia, and survival in patients with human immunodeficiency virus infection., J Infect Dis, 185, S138, 10.1086/340203 · doi:10.1086/340203
  20. Salhi, 1998, Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients., J Acquir Immune Defic Syndr Hum Retrovirol, 18, 473, 10.1097/00042560-199808150-00009 · DOI · Paper page
  21. Salmon-Ceron, 1995, Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia., J Infect Dis, 172, 656, 10.1093/infdis/172.3.656 · DOI · Paper page
  22. Beguin, 2003, Soluble transferrin receptor for the evaluation of erythropoiesis and iron status., Clin Chim Acta, 329, 9, 10.1016/S0009-8981(03)00005-6 · DOI · Paper page
  23. Cook, 1999, The measurement of serum transferrin receptor., Am J Med Sci, 318, 269, 10.1016/S0002-9629(15)40630-5 · DOI
  24. Halonen, 2003, Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters., Pediatrics, 111, 91, 10.1542/peds.111.1.91 · doi:10.1542/peds.111.1.91
  25. Worwood, 2002, Serum transferrin receptor assays and their application., Ann Clin Biochem, 39, 221, 10.1258/0004563021902152 · DOI · Paper page
  26. Beck, 2001, Selenium deficiency increases the pathology of an influenza virus infection., FASEB J, 15, 1481, 10.1096/fj.00-0721fje · DOI · Paper page
  27. Douvas, 1993, Transferrin, iron, and serum lipids enhance or inhibit Mycobacterium avium replication in human macrophages., J Infect Dis, 167, 857, 10.1093/infdis/167.4.857 · DOI · Paper page
  28. Offermann, 1996, Antioxidant-sensitive regulation of inflammatory-response genes in Kaposis sarcoma cells., J Acquir Immune Defic Syndr Hum Retrovirol, 13, 1, 10.1097/00042560-199609000-00001 · DOI
  29. Simonart, 1998, Iron as a potential co-factor in the pathogenesis of Kaposis sarcoma?, Int J Cancer, 78, 720, 10.1002/(SICI)1097-0215(19981209)78:6<720::AID-IJC9>3.0.CO;2-F · doi:10.1002/(sici)1097-0215(19981209)78:6<720::aid-ijc9>3.0.co;2-f
  30. Olsen, 2004, Low-dose iron supplementation does not increase HIV-1 load., J Acquir Immune Defic Syndr, 36, 637, 10.1097/00126334-200405010-00013 · DOI
  31. Semba, 2007, Effect of micronutrients and iron supplementation on hemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial., J Acquir Immune Defic Syndr, 45, 298, 10.1097/QAI.0b013e318050d698 · DOI
  32. Semba, 2002, High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection., J Acquir Immune Defic Syndr, 29, 142, 10.1097/00042560-200202010-00005 · DOI
  33. Traore, 2004, The effect of iron overload on in vitro HIV-1 infection., J Clin Virol, 31, S92, 10.1016/j.jcv.2004.09.011 · DOI
  34. Moore, 1998, Anemia and survival in HIV infection., J Acquir Immune Defic Syndr Hum Retrovirol, 19, 29, 10.1097/00042560-199809010-00004 · DOI · Paper page

Cited by

See all 91

Metadata

Authors
McDermid, J. M., Jaye, A., Schim van der Loeff, M. F., Todd, J., Bates, C., Austin, S., Jeffries, D., Awasana, A. A., Whittle, H. C., & Prentice, A. M.
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2007-12-01
Volume
46
Issue
4
Pages
498-507
ISSN
1525-4135 (ISSN-L)
OpenAlex
W1979522897
Cited by
91
References
4
FWCI
3.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.